Magnetic resonance imaging of neurodegenerative diseases (Q36737279)

16 August 2017

1 reference

title

Magnetic resonance imaging of neurodegenerative diseases (English)

1 reference

16 August 2017

1 reference

Hauser RA

1

1 reference

16 August 2017

Olanow CW

series ordinal

2

1 reference

16 August 2017

publication date

1 July 1994

1 reference

16 August 2017

published in

Journal of Neuroimaging

1 reference

16 August 2017

volume

4

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

146-158

1 reference

Parkinsonism and basal ganglia infarcts

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Biochemical findings in a case of parkinsonism secondary to brain tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Computerized Tomographic Correlate of Carbon Monoxide Poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Parkinsonism-plus syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Features of brain atrophy in Parkinson's disease. A CT scan study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Imaging of the aging brain. Part II. Pathologic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

The effect of age on the non-haemin iron in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Does signal-attenuation on high-field T2-weighted MRI of the brain reflect regional cerebral iron deposition? Observations on the relationship between regional cerebral water proton T2 values and iron levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Magnetic resonance imaging of the midbrain in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Magnetic resonance imaging in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

T2 relaxation time in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Multiple system atrophy (Shy-Drager syndrome): MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Striatonigral degeneration: clinical, MRI, and pathologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Progression after chronic manganese exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Clinicopathological analysis of dementia disorders in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Diffuse Lewy body disease in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Cerebral blood flow in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

The clinical diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Neuropathological findings in patients with clinical diagnoses of probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Dementia. A review emphasizing clinicopathologic correlation and brain-behavior relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Prospective neuropathological validation of Hachinski's Ischaemic Score in dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Analysis of brain and cerebrospinal fluid volumes with MR imaging: impact on PET data correction for atrophy. Part II. Aging and Alzheimer dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Alzheimer disease: measuring loss of cerebral gray matter with MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Cerebral structure on MRI, part II: Specific changes in Alzheimer's and Huntington's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Comparative analysis of computed tomographic and magnetic resonance imaging scans in Alzheimer patients and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Comparison of magnetic resonance imaging in Alzheimer's disease, vascular dementia and normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Periventricular and subcortical hyperintensities on magnetic resonance imaging. 'Rims, caps, and unidentified bright objects'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Comparison of postmortem magnetic resonance imaging and neuropathologic findings in the cerebral white matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Cognitive and Neurologic Findings in Subjects With Diffuse White Matter Lucencies on Computed Tomographic Scan (Leuko-Araiosis)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Periventricular white matter lucencies in senile dementia of the Alzheimer type and in normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

The relationship of high-intensity signals on magnetic resonance images to cognitive and psychiatric state in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

High-intensity signals in Alzheimer's disease without cerebrovascular risk factors: a magnetic resonance imaging evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Periventricular and white matter magnetic resonance imaging hyperintensities do not differ between Alzheimer's disease and normal aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Prolongation of magnetic resonance T2 time in hippocampus of human patients marks the presence and severity of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Magnetic resonance findings in patients with early-onset Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Clinical correlates of high signal lesions on magnetic resonance imaging in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

The diagnosis of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Clinical and neuropathologic assessment of severity in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Computed tomography for Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Bicaudate index in computerized tomography of Huntington disease and cerebral atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Computed Tomographic, Neurologic, and Neuropsychological Correlates of Huntington'S Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Abnormal MRI signal in the rigid form of Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Magnetic resonance imaging in huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Magnetic resonance imaging in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Central nervous system magnetic resonance imaging findings in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

MRI in patients with amyotrophic lateral sclerosis: correlation with clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Signal loss in the motor cortex on magnetic resonance images in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443146

21 January 2018

Identifiers

DOI

10.1111/JON199443146

1 reference

16 August 2017

1 reference